Moreover, p53 overexpression can occur in the absence of mutation due to the accumulation of wild-type p53 in cancer cells (Cripps et al, 1994; Dix et al, 1994), again highlighting the potential for mis-assigning p53 mutations in MSI cancers if mutation is based on overexpression of p53 protein. The gene discussed is TP53; the disease is cancer.